Pharmaceutical IT Spending Forecast in the US to

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Sep 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Payer Insights: Hepatitis C

Payer Insights: Hepatitis C

  • $ 6 495
  • Industry report
  • by Firstword Pharma
  • September 2014

The race is on for the company that can competitively price treatment regimens, share data on clinical benefit/positioning and support patient initiatives. Payer Insights: Hepatitis C, based on in-depth interviews with 12 leading healthcare payers in the US, is packed with hard-hitting, candid opinions ...

Industries: Pathology | Countries: United States

Genzyme Corporation (Symbol:GENZ) SWOT Analysis, Strategy, Revenues and Profits

Genzyme Corporation (Symbol:GENZ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • September 2014
  • 43 pages

Genzyme Corporation (Genzyme) is a biotechnology company which is principally engaged in developing and applying technologies in the life sciences to encounter unmet deadly diseases. Its products and services are focused on rare genetic disorders, kidney diseases, orthopedics, organ transplant, cancer, ...

Industries: Pathology | Countries: United States

Agenus, Inc. (Symbol:AGEN) SWOT Analysis, Strategy, Revenues and Profits

Agenus, Inc. (Symbol:AGEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • September 2014
  • 47 pages

Agenus Inc (Agenus), formerly known as Antigenics, Inc., is a biotechnology company engaged in the development of superior health care products and technologies to treat various forms of cancers, infectious diseases and autoimmune disorders based on immunological approaches. The company is focused on ...

Industries: Pathology | Countries: United States

Hyperion Therapeutics, Inc. (HPTX) - Financial and Strategic SWOT Analysis Review

Hyperion Therapeutics, Inc. (HPTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • by Global Data
  • September 2014
  • 49 pages

Hyperion Therapeutics, Inc. (HPTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses ...

Industries: Therapy | Countries: United States

Post Menopausal Osteoporosis - Pipeline Review, H2 2014

Post Menopausal Osteoporosis - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 80 pages

Post Menopausal Osteoporosis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Post Menopausal Osteoporosis - Pipeline Review, H2 2014', provides an overview of the Post Menopausal Osteoporosis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development ...

Industries: Pathology | Countries: World, Finland, United States

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 192 pages

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014', provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL)'s therapeutic pipeline. This report provides ...

Industries: Pathology | Countries: United States, World

Banyan Biomarkers, Inc. - Product Pipeline Analysis, 2014 Update

Banyan Biomarkers, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • September 2014
  • 35 pages

Summary Banyan Biomarkers, Inc. (Banyan) is a diagnostic company. The company research and develops in vitro diagnostic products to detect traumatic brain injuries. Its services include therapies for organ injury such as traumatic brain injuries. The company's research programs concentrates in the areas ...

Industries: Pathology | Countries: United States

Hayat Pharmaceutical Industries Co PSC

Hayat Pharmaceutical Industries Co PSC

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 56 pages

A textual analysis of the financial results for Hayat Pharmaceutical Industries Co PSC compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical | Countries: United States

Physiotherapy Equipment Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications (Pediatric, Musculoskeletal) & by End Users (Hospitals), Advanced technologies - Global Forecast to 2019

Physiotherapy Equipment Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications (Pediatric, Musculoskeletal) & by End Users (Hospitals), Advanced technologies - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • September 2014
  • 168 pages

Developing markets such as Middle East, Australia, New Zealand, China, India, and Malaysia are lucrative markets for physiotherapy equipment, owing to favorable government incentives and developing healthcare infrastructure. The report segments the global physiotherapy equipment market by product, application, ...

Industries: Therapy | Countries: World, North America, Europe, Germany, Canada, United States, China, Australia

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.